Un Underestimated Symptom of Aortic Stenosis

For the first time, this long term observational study on a large cohort of contemporary patients with aortic stenosis (AS), has shown syncope is an underestimated threat, associated with worse prognosis after surgical aortic valve replacement (SAVR).

¿Qué usar para medir funcionalmente una lesión coronaria en el contexto de estenosis aórtica severa?It is interesting to note that other symptoms or early signs of AS that will normally indicate SAVR (dyspnea, angina or ventricular function deterioration) are associated with significantly better prognosis after SAVR. Patients presenting syncope usually display a specific pathophysiologic phenotype characterized by a smaller aortic valve area, smaller cardiac cavities, and lower stroke volumes.

 

The decision to replace the aortic valve is not always easy and requires thorough risk/Benefit ratio assessment.


Read also: Clinical Events after Deferral of LAD Treatment Guided by FFR or iFR.


Cardinal symptoms that indicate SAVR are angina, cardiac failure and syncope; however, it remains unclear whether these symptoms convey increased risk after SAVR or whether early detection, even when subtle, should be emphasized in the clinical practice.

 

A total 625 patients with isolated AS receiving elective SAVR were prospectively enrolled in this long-term study.

 

Patients presenting syncope had significantly smaller ventricular diameters (p=0.02), as well as smaller atrial diameters.


Read also: How long should we wait with asymptomatic aortic stenosis and preserved LVEF?


They also had smaller valve areas (p=0.048) and lower stroke index volume.

 

After adjusting for variables, syncope was associated with over 100% increased mortality risk  (HR 2.27, p=0.04) at one year, and again, over 100% increased mortality risk (HR 2.11, p<0.001) at 10 years. On the contrary, dyspnea, angina or preoperatory ventricular failure were not associated with worse evolution after SAVR.

 

Original title: Syncope. The Underestimated Threat in Severe Aortic Stenosis.

Reference: Georg Goliasch et al. J Am Coll Cardiol Img 2019. Article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....